Hello everyone,
I am researching three silver sulphide QDs that a collaborating group have synthesised - the cores are all the same size (around 3nm). One is coated in 2MPA, another coated in 2MPA and a targeting peptide, and the last one is conjugated to 2MPA and cetuximab on a PEG linker (probably 1 or 2 antibodies per QD). Hydrodynamic size from DLS suggests that the QD-2MPA is 4.2nm (which makes sense), the QD-2MPA-peptide is 4.8nm (still makes sense) but the QD-2MPA-cetuximab comes back as 5.9nm. On the presumption that an antibody is around 10nm, this must be an underestimate. The first two particles will be spherical, whereas two antibodies on a QD (or even one) will make a non-spherical object, that should be at least 10nm in size. However, I can't find a reference/paper online that explains why DLS might be underestimating the hydrodynamic diameter of a QD-antibody nanoconjugate. I presumed it was shape related, but cannot find published evidence confirming this. Can anyone explain this result, and ideally provide a reference?
Many thanks in advance.